EUVIMEDEUVIMED entdecken
Crossref

Identification of potential pharmacological chaperones that selectively stabilize mutated Aspartoacylases in Canavan disease

Nitesh Kumar Poddar, Yasanandana S Wijayasinghe, Ronald E Viola

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2024

DOI: 10.1016/j.bbapap.2024.141043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2024. Verfasst von Nitesh Kumar Poddar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Manipal University Jaipur, Jaipur-Ajmer Express Highway, Dehmi Kalan, Near GVK Toll Plaza, Jaipur, Rajasthan 303007, India…. Hauptthemen laut MEDLINE: Canavan Disease, Amidohydrolases. Die Arbeit nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Canavan disease is caused by mutations in the ASPA gene, leading to diminished catalytic activity of aspartoacylase in the brain. Clinical missense mutations are found throughout the enzyme structure, with many of these mutated enzymes having not only decreased activity but also compromised stability. High-throughput screening of a small molecule library has identified several compounds that significantly increase the thermal stability of the E285A mutant enzyme, the most predominant clinical mutation in Canavan disease, while having a negligible effect on the native enzyme. Based on the initial successes, some structural analogs of these initial hits were selected for further examination. Glutathione, NAAG and patulin were each confirmed to be competitive inhibitors, indicating the binding of these compounds at the dimer interface or near the active site of the E285A enzyme. The experimental results were theoretically examined with the help of the docking analysis method. The structure activity-guided optimization of these compounds can potentially lead to potential pharmacological chaperones that could alleviate the detrimental effect of ASPA mutations in Canavan patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Canavan DiseaseAmidohydrolasesHumansMolecular Docking SimulationEnzyme StabilityMutation, MissenseSmall Molecule LibrariesCatalytic DomainMutationHigh-Throughput Screening Assays

Stichwörter der Autor:innen

AspartoacylaseCanavan diseaseEnzyme inhibitorsHigh-throughput screeningPharmacological chaperonesThermoFluor

Substanzen

AmidohydrolasesaspartoacylaseSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Biosciences, Manipal University Jaipur, Jaipur-Ajmer Express Highway, Dehmi Kalan, Near GVK Toll Plaza, Jaipur, Rajasthan 303007, India; Department of Chemistry and Biochemistry, The University of Toledo,…
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Chemistry and Biochemistry, The University of Toledo, Toledo, OH 43606, USA.
  • Department of Chemistry and Biochemistry, The University of Toledo, Toledo, OH 43606, USA.

Zitieren

APA

Poddar, N. K., Wijayasinghe, Y. S., & Viola, R. E. (2024). Identification of potential pharmacological chaperones that selectively stabilize mutated Aspartoacylases in Canavan disease. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. https://doi.org/10.1016/j.bbapap.2024.141043

Vancouver

Poddar NK, Wijayasinghe YS, Viola RE. Identification of potential pharmacological chaperones that selectively stabilize mutated Aspartoacylases in Canavan disease. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2024. doi:10.1016/j.bbapap.2024.141043

BibTeX
@article{Poddar2024,
  author = {Poddar, Nitesh Kumar and Wijayasinghe, Yasanandana S and Viola, Ronald E},
  title = {Identification of potential pharmacological chaperones that selectively stabilize mutated Aspartoacylases in Canavan disease},
  journal = {Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics},
  year = {2024},
  doi = {10.1016/j.bbapap.2024.141043}
}
Kostenlos starten →